The purpose of this article is to review the currently available assessment tools for measuring renal function, body weight, and body surface area in the amputee population.
Methods:
PubMed and Web of Science were searched using the following key terms: amputation, dose adjustment, and estimation of body weight. Articles published in languages other than English were excluded from the search.
Results:
Despite the increasing prevalence of amputations, there is little literature available that discusses its impact on the patient and how these physiological changes can affect pharmacokinetics. Very little information is available to guide dose adjustment in this patient population. This article discusses several factors to consider when determining optimum dosing regimens in patients with different levels of amputations.
Conclusion:
This article will evaluate the applicability of methods mentioned in existing literature for measuring changes in renal function, body weight, and body surface area in amputees.
Ziegler-GrahamKMacKenzieEEphraimP, et al.Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehabil. 2008;89(3):422–429.
2.
DillinghamTRPezzinLEMacKenzieEJ. Limb amputation and limb deficiency: epidemiology and recent trends in the United States. South Med J. 2002;95(8):875–883.
3.
GeissLSLiYHoraIAlbrightA, et al.Resurgence of diabetes-related nontraumatic lower-extremity amputation in the young and middle-aged adult U.S. population. Diabetes Care. 2019;42(1):50–54.
4.
DillinghamTRPezzinLEShoreAD. Reamputation, mortality, and health care costs among persons with dysvascular lower-limb amputations. Arch Phys Med Rehabil. 2005;86(3):480–486.
5.
JohannessonALarssonGURamstrandN, et al.Incidence of lower-limb amputation in the diabetic and nondiabetic general population: a 10-year population-based cohort study of initial unilateral and contralateral amputations and reamputations. Diabetes Care. 2009;32(2):275–280.
6.
PemayunTGNaibahoRMNovitasariD, et al.Risk factors for lower extremity amputation in patients with diabetic foot ulcers: a hospital-based case–control study. Diabet Foot Ankle. 2015;6:29629. Accessed February 22, 2020.
7.
ErstadBL. Designing drug regimens for special intensive care unit populations. World J Crit Care Med. 2015;4(2):139–151.
8.
OsterkampLK. Current perspective on assessment of human body proportions of relevance to amputees. J Am Diet Assoc. 1995;95(2):215–218.
9.
BaileyJAwudiEKalaniC, et al.Accuracy of calculated creatinine among amputees: case presentation and literature review. Crit Care Shock. 2019;22(4). Accessed November 4, 2019.
10.
Du BoisDDu BoisEF. A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition. 1989;5(5):303–311; discussion 312-313.
11.
KaestnerSASewellGJ. Chemotherapy dosing part I: scientific basis for current practice and use of body surface area. Clin Oncol (R Coll Radiol). 2007;19(1):23–37.
12.
OwenDO’ReillyEMAngC, et al.Optimal chemotherapy dosing in a bilateral lower extremities amputee with metastatic pancreatic adenocarcinoma. Gastrointest Cancer Res. 2013;6(3):93–94.
13.
KnaysiGACrikelairGFCosmanB. The rule of nines: its history and accuracy. Plast Reconstr Surg. 1968;41(6):560–563.
14.
ColangeloPMWelchDWRichDS, et al.Two methods for estimating body surface area in adult amputees. Am J Hosp Pharm. 1984;41(12):2650–2655.
15.
NeamanKCAndresLAMcClureAM, et al.A new method for estimation of involved BSAs for obese and normal-weight patients with burn injury. J Burn Care Res. 2011;32(3):421–428.
16.
AakjærMHoulindMBTreldalC, et al.Differences in kidney function estimates based on creatinine and/or cystatin C in non-traumatic amputation patients and their impact on drug prescribing. J Clin Med. 2019;8(1):89.
17.
ImEEStewartIJMorrowBD, et al.Retrospective review of serum creatinine and creatinine-based measures of estimated glomerular filtration rate in an amputee population. Mil Med. 2012;177(8):952–956.
18.
CockcroftDWGaultMH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.
19.
LeveyASBoschJPLewisJB, et al.A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med.1999;130(6):461–470.
20.
FergusonTWKomendaPTangriN. Cystatin C as a biomarker for estimating glomerular filtration rate. Curr Opin Nephrol Hypertens. 2015;24(3):295–300.
21.
BaxmannACAhmedMSMarquesNC, et al.Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol. 2008;3(2):348–354.
22.
ThurlowJSAbbottKCLinbergA, et al.SCr and SCysC concentrations before and after traumatic amputation in male soldiers: a case-control study. Am J Kidney Dis. 2014;63(1):167–170.
23.
van GorpFvan RensTMKuckEM, et al.Dosing of carboplatin in a patient with amputated legs: a case report. J Oncol Pharm Pract. 2014;20(6):473–475.
24.
CalvertAHNewellDRGumbrellLA, et al.Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol. 1989;7(11):1748–1756.
25.
NicholsKREdisonKMRosenbaumMD, et al.Vancomycin and gentamicin pharmacokinetic alterations in an adolescent amputee. J Pediatr Pharmacol Ther. 2013;18(1):63–66.
26.
TsubokawaTOhtaKTashiroK, et al.Propofol pharmacokinetics in a patient with bilateral leg amputation. J Anesth. 2003;17(2):147–148.
RobakTJamroziakKGora-TyborJ, et al.Comparison of cladribine plus cyclophosphamide with fludarabine plus cyclophosphamide as first-line therapy for chronic lymphocytic leukemia: a phase III randomized study by the Polish Adult Leukemia Group (PALG-CLL3 Study). J Clin Oncol. 2010;28(11):1863–1869.
CarverJRShapiroCLNgA, et al.American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol. 2007;25(25):3991–4008.
31.
ThomasDASarrisAHCortesJ, et al.Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia. Cancer. 2006;106(1):120–127.
